Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Robertson

Showing results (131-140 of 200) with videos related to

Pageof 20
Sort By:
Endocrine-Related Cancer|August 23, 2005
Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancerJ M Gee, J F Robertson, E Gutteridge, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1989
Endocrine effects of combination antioestrogen and LH-RH agonist therapy in premenopausal patients with advanced breast cancerK J Walker, R F Walker, A Turkes, et al.
Breast Cancer Research and Treatment|January 1, 1996
Prognostic significance of serum c-erbB-2 protein in breast cancer patientsP C Willsher, J Beaver, S Pinder, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Assessment of four monoclonal antibodies as serum markers in breast cancerJ F Robertson, D Pearson, M R Price, et al.
British Journal of Cancer|July 1, 1996
Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182780 in women with advanced breast cancerA Howell, D J DeFriend, J F Robertson, et al.
Breast (Edinburgh, Scotland)|January 1, 2008
Incidence of intramammary nodes in completion mastectomy specimens after axillary node sampling: implications for breast conserving surgeryR S Rampaul, O T Dale, M Mitchell, et al.
The Journal of Pathology|July 9, 1999
p21(WAF1) expression and endocrine response in breast cancerR A McClelland, J M Gee, L O'Sullivan, et al.
Breast Cancer Research and Treatment|March 23, 2001
Change in expression of ER, bcl-2 and MIB1 on primary tamoxifen and relation to response in ER positive breast cancerF S Kenny, P C Willsher, J M Gee, et al.
The British Journal of Surgery|December 1, 1992
Tumour oestrogen receptor content allows selection of elderly patients with breast cancer for conservative tamoxifen treatmentS C Low, A R Dixon, J Bell, et al.
Hormone Research|January 1, 1989
Review of the endocrine actions of luteinising hormone-releasing hormone analogues in premenopausal women with breast cancerR I Nicholson, K J Walker, R F Walker, et al.
Pageof 20

Showing results (131-140 of 200) with videos related to

Sort By:
Pageof 20
Endocrine-Related Cancer|August 23, 2005
Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancerJ M Gee, J F Robertson, E Gutteridge, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1989
Endocrine effects of combination antioestrogen and LH-RH agonist therapy in premenopausal patients with advanced breast cancerK J Walker, R F Walker, A Turkes, et al.
Breast Cancer Research and Treatment|January 1, 1996
Prognostic significance of serum c-erbB-2 protein in breast cancer patientsP C Willsher, J Beaver, S Pinder, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Assessment of four monoclonal antibodies as serum markers in breast cancerJ F Robertson, D Pearson, M R Price, et al.
British Journal of Cancer|July 1, 1996
Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182780 in women with advanced breast cancerA Howell, D J DeFriend, J F Robertson, et al.
Breast (Edinburgh, Scotland)|January 1, 2008
Incidence of intramammary nodes in completion mastectomy specimens after axillary node sampling: implications for breast conserving surgeryR S Rampaul, O T Dale, M Mitchell, et al.
The Journal of Pathology|July 9, 1999
p21(WAF1) expression and endocrine response in breast cancerR A McClelland, J M Gee, L O'Sullivan, et al.
Breast Cancer Research and Treatment|March 23, 2001
Change in expression of ER, bcl-2 and MIB1 on primary tamoxifen and relation to response in ER positive breast cancerF S Kenny, P C Willsher, J M Gee, et al.
The British Journal of Surgery|December 1, 1992
Tumour oestrogen receptor content allows selection of elderly patients with breast cancer for conservative tamoxifen treatmentS C Low, A R Dixon, J Bell, et al.
Hormone Research|January 1, 1989
Review of the endocrine actions of luteinising hormone-releasing hormone analogues in premenopausal women with breast cancerR I Nicholson, K J Walker, R F Walker, et al.
Pageof 20